Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 2
2005 3
2006 3
2007 2
2008 2
2009 1
2010 5
2011 2
2012 7
2013 5
2014 5
2015 5
2016 7
2017 4
2018 5
2019 8
2020 8
Text availability
Article attribute
Article type
Publication date

Search Results

68 results
Results by year
Filters applied: . Clear all
Page 1
Quorum Sensing as Antivirulence Target in Cystic Fibrosis Pathogens.
Scoffone VC, Trespidi G, Chiarelli LR, Barbieri G, Buroni S. Scoffone VC, et al. Among authors: chiarelli lr. Int J Mol Sci. 2019 Apr 13;20(8):1838. doi: 10.3390/ijms20081838. Int J Mol Sci. 2019. PMID: 31013936 Free PMC article. Review.
Mycobacterium abscessus, an Emerging and Worrisome Pathogen among Cystic Fibrosis Patients.
Degiacomi G, Sammartino JC, Chiarelli LR, Riabova O, Makarov V, Pasca MR. Degiacomi G, et al. Int J Mol Sci. 2019 Nov 22;20(23):5868. doi: 10.3390/ijms20235868. Int J Mol Sci. 2019. PMID: 31766758 Free PMC article. Review.
Burkholderia cenocepacia Infections in Cystic Fibrosis Patients: Drug Resistance and Therapeutic Approaches.
Scoffone VC, Chiarelli LR, Trespidi G, Mentasti M, Riccardi G, Buroni S. Scoffone VC, et al. Among authors: chiarelli lr. Front Microbiol. 2017 Aug 22;8:1592. doi: 10.3389/fmicb.2017.01592. eCollection 2017. Front Microbiol. 2017. PMID: 28878751 Free PMC article. Review.
New prodrugs against tuberculosis.
Mori G, Chiarelli LR, Riccardi G, Pasca MR. Mori G, et al. Drug Discov Today. 2017 Mar;22(3):519-525. doi: 10.1016/j.drudis.2016.09.006. Epub 2016 Sep 17. Drug Discov Today. 2017. PMID: 27649942 Review.
Competitive Fitness of Essential Gene Knockdowns Reveals a Broad-Spectrum Antibacterial Inhibitor of the Cell Division Protein FtsZ.
Hogan AM, Scoffone VC, Makarov V, Gislason AS, Tesfu H, Stietz MS, Brassinga AKC, Domaratzki M, Li X, Azzalin A, Biggiogera M, Riabova O, Monakhova N, Chiarelli LR, Riccardi G, Buroni S, Cardona ST. Hogan AM, et al. Among authors: chiarelli lr. Antimicrob Agents Chemother. 2018 Nov 26;62(12):e01231-18. doi: 10.1128/AAC.01231-18. Print 2018 Dec. Antimicrob Agents Chemother. 2018. PMID: 30297366 Free PMC article.
Phenylacetyl Coenzyme A, Not Phenylacetic Acid, Attenuates CepIR-Regulated Virulence in Burkholderia cenocepacia.
Lightly TJ, Frejuk KL, Groleau MC, Chiarelli LR, Ras C, Buroni S, D├ęziel E, Sorensen JL, Cardona ST. Lightly TJ, et al. Among authors: chiarelli lr. Appl Environ Microbiol. 2019 Nov 27;85(24):e01594-19. doi: 10.1128/AEM.01594-19. Print 2019 Dec 15. Appl Environ Microbiol. 2019. PMID: 31585996 Free PMC article.
Iron Acquisition Pathways as Targets for Antitubercular Drugs.
Meneghetti F, Villa S, Gelain A, Barlocco D, Chiarelli LR, Pasca MR, Costantino L. Meneghetti F, et al. Curr Med Chem. 2016;23(35):4009-4026. doi: 10.2174/0929867323666160607223747. Curr Med Chem. 2016. PMID: 27281295 Review.
New and Old Hot Drug Targets in Tuberculosis.
Chiarelli LR, Mori G, Esposito M, Orena BS, Pasca MR. Chiarelli LR, et al. Curr Med Chem. 2016;23(33):3813-3846. doi: 10.2174/1389557516666160831164925. Curr Med Chem. 2016. PMID: 27666933 Review.
An Overview on the Potential Antimycobacterial Agents Targeting Serine/Threonine Protein Kinases from Mycobacterium tuberculosis.
Mori M, Sammartino JC, Costantino L, Gelain A, Meneghetti F, Villa S, Chiarelli LR. Mori M, et al. Curr Top Med Chem. 2019;19(9):646-661. doi: 10.2174/1568026619666190227182701. Curr Top Med Chem. 2019. PMID: 30827246 Review.
Discovery and development of novel salicylate synthase (MbtI) furanic inhibitors as antitubercular agents.
Chiarelli LR, Mori M, Barlocco D, Beretta G, Gelain A, Pini E, Porcino M, Mori G, Stelitano G, Costantino L, Lapillo M, Bonanni D, Poli G, Tuccinardi T, Villa S, Meneghetti F. Chiarelli LR, et al. Eur J Med Chem. 2018 Jul 15;155:754-763. doi: 10.1016/j.ejmech.2018.06.033. Epub 2018 Jun 18. Eur J Med Chem. 2018. PMID: 29940465 Free article.
68 results
Jump to page
Feedback